Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Valuation
Trading at 14.8× earnings vs its 13.2× historical median P/E.
Fair value ≈ $0.14 · price $0.16 today
Overvalued · 12% above
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$ETST - Earth Science Tech, Inc. - 10K - Updated Risk Factors
ETST sharpens risks around dependence on MOC Teledoc’s provider network and CPOM compliance, plus new exposure from FDA 503A compounding rules and drug-shortage changes that could abruptly shut profitable pharmacy lines and hit revenue. #PharmaceuticalCompliance #ProviderNetworkRisk #FDARegulations #DrugShortages #RevenueImpact
🟢 Added 🟠 Removed
https://d-risk.ai/ETST/10-K/2026-06-18
$ETST files its audited Form 10-K for the fiscal year ended March 31, 2026.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001538495/000149315226029160/form10-k.htm
$ETST - Earth Science Tech, Inc. - 10K - Updated Risk Factors
ETST sharpens risks around dependence on MOC Teledoc’s provider network and CPOM compliance, plus new exposure from FDA 503A compounding rules and drug-shortage changes that could abruptly shut profitable pharmacy lines and hit revenue. #PharmaceuticalCompliance #ProviderNetworkRisk #FDARegulations #DrugShortages #RevenueImpact
🟢 Added 🟠 Removed
https://d-risk.ai/ETST/10-K/2026-06-18
$ETST Annual Shareholder Letter for FY Ended March 31, 2026
https://www.globenewswire.com/news-release/2026/06/10/3309707/0/en/earth-science-tech-inc-etst-annual-shareholder-letter-for-fy-ended-march-31-2026.html?_gl=1*sod64e*_up*MQ..*_ga*OTA0NTkwNzUzLjE3ODEwOTYwNzk.*_ga_B6167QB2TF*czE3ODEwOTYwNzkkbzEkZzAkdDE3ODEwOTYwNzkkajYwJGwwJGgyODQ1NjQ1ODE.*_ga_ERWPGTJ5X8*czE3ODEwOTYwNzkkbzEkZzAkdDE3ODEwOTYwNzkkajYwJGwwJGgw
